Hemophagocytosis in Critically Ill Adult Patients

NCT01913938 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-01-17

No results posted yet for this study

Summary

The purpose of the study is to find out whether non-responsiveness to therapeutic recombinant human granulocyte colony-stimulation factor (rhG-CSF) is associated with hemophagocytosis in critically ill adult patients with cytopenias.

Conditions

  • Hemophagocytosis

Sponsors & Collaborators

  • University of Ulm

    lead OTHER

Principal Investigators

  • Manfred E Weiss, MD · Department of Anesthesiology

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2025-07-31
Completion
2026-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01913938 on ClinicalTrials.gov